Introduction
Hallucinogens are a controversial group of drugs to which a broad range of conflicting health effects have been attributed. (Abramson, 1967) .
However, the widespread recreational use of these drugs in the 1960s resulted in a number of highly publicised adverse health reactions, and further research on the hallucinogen class of drugs was prohibited. This situation lasted until restrictions were gradually eased especially from the 1990s onwards, and the appear-tigating the psychological and spiritual effects of psilocybin (the active ingredient of "magic mushrooms") gave a new impetus to research in the field (Griffiths, Richards, McCann, & Jesse, 2006; Griffiths, Richards, Johnson, McCann, & Jesse, 2008; MacLean, Johnson, & Griffiths, 2011) . In this study, thirty hallucinogen-naïve vol- 
Literature review
Clinical trials of hallucinogens in substance dependence are now once more being performed, although currently for the most part as pilot or proof-of-concept studies. Recently, such studies have suggested the value of psilocybin in treating nicotine dependence (Johnson, GarciaRomeu, Cosimano, & Griffiths, 2014) and alcohol dependence (Bogenschutz et al., 2015) , the value of ibogaine in the treatment of alcohol, cannabis, cocaine and crack dependence (Schenberg, de Castro Comis, Chaves, & da Silveira, 2014) and also the value of ayahuasca in treating alcohol, tobacco and cocaine dependence (Thomas, Lucas, Capler, Tupper, & Martin, 2013) . None of the studies discovered any clinically significant adverse reactions to the hallucinogenic treatment.
While larger controlled trials are necessary to confirm these preliminary results, they are congruent with early findings on the therapeutic use of hallucinogens in the treatment of substance use disorders.
A recent meta-analysis of single-dose LSD treatment of alcoholism in the 1960s revealed significant therapeutic effect at short (two to three months) and medium (six months) periods post-treatment, but no significant effect in the long term (twelve months) (Krebs & Johansen, 2012) .
Recent research has also obtained preliminary evidence for the therapeutic effect of psilocybin (Grob et al., 2011) and LSD (Gasser et al., 2013) for anxiety in patients with life-threatening diseases. Both
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It is difficult to understand how a few doses of hallucinogenic substances could have such positive therapeutic effect, and some have suggested that the efficacy of hallucinogens in the treatment of substance abuse stems from their reliable capacity of delivering transformative "peak experiences" that are similar in some ways to religious epiphanies (Strassman, 1995) .
In a recent review article, Majić, Schmidt and Gallinat (2015) see evidence for therapeutic effect on both biological and experiential levels, suggesting that the specifically hallucinogenic aspect of these drugs cannot be ignored in their administration as treatment.
With the rise of modern brain imaging techniques it has become possible to obtain more specific knowledge of how hallucinogenic drugs act on the brain. It has been known for quite a while that the classic hallucinogens mescaline, psilocybin and LSD all work by an agonist or partial agonist action on the serotonin 5-HT 2A receptors (Iversen, Iversen, Bloom, & Roth, 2009; Nichols, 2004) , but it has also been commonly assumed that they "enhance excitatory neurotransmission and overall brain activity" (Lee & Roth, 2012 , p. 1821 .
Research by Carhart-Harris, Erritzoe, and collaborators (2012) challenges this assumption, finding that psilocybin caused "decreased activity and connectivity in the brain's key connector hubs, enabling a state of unconstrained cognition" (p. 2138).
Rather than causing the expected upsurge of possibly frivolous activity, psilocybin reduced activity in the default-mode network, which earlier research has identified as implicated in a baseline mode of brain function (Raichle et al., 2001) . It is worth mentioning that a relative deactivation of the default-mode network has also been discovered in experienced meditators both during the practice of meditation and in an ordinary resting state (Brewer et al., 2011) . Consistent with the finding by CarhartHarris, is the discovery that psilocybin can have a defocusing effect on semantic networks that leads to "an increased availability of remote associations and thereby may bring cognitive contents to mind that under normal circumstances remain non-activated" (Spitzer et al., 1996 (Spitzer et al., , pp. 1056 (Spitzer et al., -1057 that "the use of psychedelic drugs with a purpose to enhance self-knowledge is less associated with problems, and correlates positively with coping and spirituality" (Móró, Simon, Bárd, & Rácz, 2011, p. 188) ; it concludes with a call for further qualitative investigations into these effects.
The field of qualitative studies remains however sparsely populated, and especially so with regard to hallucinogenic drugs, although some work on general drug use has implications also for users of hallucinogens. One important study in this regard is Aaslid's (2007) in-depth interviews with Norwegian drug users, through which she identified three usage patterns that she la- The study should therefore be taken to reflect the "best practices" of a generally resourceful and predominantly male group of hallucinogen users.
Data collection
Interviews were conducted on a semistructured basis, with the aim of obtaining a naturally flowing conversation relating to a number of specific research questions.
Participants in group interviews respond to a more restricted line of questions pertaining mainly to one specific topic.
Typical questions used to guide the interview.
• Why do you use hallucinogenic drugs?
• Can you describe some hallucinogenic experiences that were important to you?
• How do you feel your hallucinogen use has influenced your life for better or worse?
• Have you ever felt that you were overdoing or abusing drugs?
• Have you ever experienced healing of physical or psychological issues as a result of using hallucinogenic drugs?
Transcription and analysis
As interviews took the form of written There was a moment when we all realised that the love and warmth we felt for each other was real, and that we had chosen each other for this interaction. We are all very good friends today, 12-13 years later (ID17).
Results

Drug use
Positive consequences
Respondents described a number of posi- I believe it has something to do with the serotonin that is released, but also with how positive the experience is, and with that feeling of total freedom from worry that one can experience and carry into daily life. It is also helpful to have shared a moment of complete joy with close friends (ID17).
Adverse consequences
One of the potential dangers of using hallucinogenic drugs is that one can have difficult, scary and perhaps damaging experiences. Many participants had been through such "bad trips", but most of these It is possible to develop a kind of dependency, but MDMA is very self-regulating in that if you take it more than a few days in a row, it simply doesn't work like it used to. For this reason use tends to limit itself, which is one of the reasons why I think MDMA is among the safest drugs of all (ID17).
Probably the greatest danger with hallucinogen use is that it could lead to lasting mental health problems. While several participants reported temporary experiences of mental chaos and confusion while under the effect of hallucinogens -something that might be termed a "bad trip" -only a few described long-term consequences of this kind.
Ayahuasca was beautiful to me. (Bogenschutz et al., 2015; Johnson et al., 2014; Schenberg et al., 2014; Thomas et al., 2013) are thus corroborated by the participants of this study, who furthermore perceive both biological and transformative-experiential aspects to these healing processes. The aim of qualitative research is in any case not to be generalisable, but to obtain insight into individual experiences (Wright et al., 2015) . As far as the inter- 
